Funding for this research was provided by:
National Institute of General Medical Sciences (GM132713)
Children's Hospital of Philadelphia
Received: 18 September 2020
Accepted: 4 June 2021
First Online: 17 June 2021
: The genomic study on patients with acute myeloid leukemia was carried out under IRB-approved protocol (# HS-20-00223). The patient has given written informed consent for publication. The experimental methods comply with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.